|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Longboard Pharmaceuticals, Inc. (LBPH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
16,920,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. Co. is focused on developing the following product candidates: LP352, an oral, centrally acting, 5-hydroxytryptamine 2c receptor subtype, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies; LP659, a centrally acting, sphingosine-1-phosphate receptor subtypes 1 and 5 modulator in preclinical studies for multiple neurological diseases; and LP143, a centrally acting, full cannabinoid type 2 receptor agonist in preclinical studies for central nervous system diseases and disorders.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
3,978,540 |
3,978,540 |
3,978,540 |
| Total Sell Value |
$0 |
$96,479,595 |
$96,479,595 |
$96,479,595 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
1 |
1 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kaye Randall |
CMO |
• – – |
2024-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,920 |
17,920 |
|
- |
|
| Roberts Brandi |
CFO |
• – – |
2024-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,090 |
15,090 |
|
- |
|
| Arena Pharmaceuticals Inc |
Former 10% Owner |
– – – |
2024-01-25 |
4 |
S |
$24.25 |
$96,479,595 |
D/D |
(3,978,540) |
0 |
|
- |
|
| Arena Pharmaceuticals Inc |
10% Owner |
– – • |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
138,000 |
3,978,540 |
|
- |
|
| Lind Kevin Robert |
President and CEOOfficer |
• • – |
2021-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
348,450 |
|
- |
|
| Arena Pharmaceuticals Inc |
10% Owner |
– – • |
2021-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,840,540 |
|
- |
|
6 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
